Publications by authors named "Yuto Shiode"

Article Synopsis
  • - Current treatments for hepatitis B virus (HBV) do not effectively remove its DNA form (cccDNA), but researchers are exploring the use of the CRISPR/Cas9 system to target and reduce cccDNA levels.
  • - The study found that inhibiting DNA repair processes, particularly those handled by PARP2 and DNA Ligase 4, can enhance the effectiveness of CRISPR in reducing HBV replication markers in infected liver cells.
  • - Additionally, using the PARP inhibitor olaparib further boosted the effectiveness of CRISPR by lowering levels of HBV-related RNA and cccDNA, highlighting a potential new combination therapy for HBV.
View Article and Find Full Text PDF

Background And Aims: Intrahepatic cholangiocarcinoma (ICC) is a deadly but poorly understood disease, and its treatment options are very limited. The aim of this study was to identify the molecular drivers of ICC and search for therapeutic targets.

Approach And Results: We performed a Sleeping Beauty transposon-based in vivo insertional mutagenesis screen in liver-specific Pten -deficient mice and identified TNF receptor-related factor 3 ( Traf3 ) as the most significantly mutated gene in murine ICCs in a loss-of-function manner.

View Article and Find Full Text PDF

Grb2-associated binder 1 (Gab1) is an adaptor protein that is important for intracellular signal transduction by receptor tyrosine kinases that are receptors for various growth factors and plays an important role in rapid liver regeneration after partial hepatectomy and during acute hepatitis. On the other hand, mild liver regeneration is induced in livers of individuals with chronic hepatitis, where hepatocyte apoptosis is persistent; however, the impact of Gab1 on such livers remains unclear. We examined the role of Gab1 in chronic hepatitis.

View Article and Find Full Text PDF
Article Synopsis
  • Autophagy is a cellular process that maintains balance in cells, but its relationship with Hepatitis C virus (HCV) infection was examined in this study, showing that HCV reduces autophagy and increases the protein Rubicon.
  • Knocking down Rubicon in HCV-infected liver cells promoted autophagy and led to increased HCV replication, while overexpressing Rubicon or using autophagy inhibitors suppressed autophagy and activated the immune response.
  • In humanized mouse models, HCV infection raised Rubicon levels and enhanced immune signaling, and reducing HCV led to decreased Rubicon, highlighting its role in HCV replication and the body’s immune response.
View Article and Find Full Text PDF

Unlabelled: Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. It encompasses a spectrum ranging from simple steatosis to fatty liver with hepatocellular injury, termed nonalcoholic steatohepatitis. Recent studies have demonstrated hepatic autophagy being impaired in NAFLD.

View Article and Find Full Text PDF